Search
Search
Research shared and celebrated at 17th Annual Mental Health Research Half Day
From falls prevention to depression therapies, scientists at Lawson Health Research Institute are conducting important mental health studies. Held on Thursday, September 15, the 17th Annual Mental Health Research Half Day at the Parkwood Institute Mental Health Program was a chance to share and celebrate this research.
The Mental Health Research Half Day featured poster and oral presentations, as well as the 12th Annual Tony Cerenzia Research Lecture. Clinical, administrative and research staff attended to learn more about research happening at Parkwood Institute and the Southwest Centre for Forensic Mental Health Care, part of the St. Joseph’s Health Care London family.
“The Mental Health Research Half Day provides an opportunity for researchers at Parkwood Institute and the Southwest Centre for Forensic Mental Health Care to present their research findings to clinical and administrative staff,” said Dr. Richard O’Reilly, Director of Psychiatric Research at Parkwood Institute & Southwest Centre and a Scientist at Lawson. “It is important that all clinical staff, who may not be directly involved in research, know what studies are being conducted and their impact on patient care.”
The 12th Annual Tony Cerenzia Research Lecture was delivered by Dr. Nathan Herrmann, Associate Scientist, Evaluative Clinical Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute and Head of the Division of Geriatric Psychiatry at Sunnybrook Health Sciences Centre. Dr. Herrmann delivered an engaging lecture titled “Managing Neuropsychiatric Symptoms in Dementia: An Evidence-Based Approach”.
Attendees were engaged not only by this highly informative lecture but also by the poster and oral presentations which covered a broad range of research topics. Presenters were also enthusiastic about the day and the opportunities it provided.
“The Mental Health Research Half Day is a great event which provides networking opportunities here at Parkwood Institute. It allows staff from across St. Joseph’s to learn about different research happening across program areas,” said Erin Finley, an Occupational Therapist (OT) in Geriatric Psychology at Parkwood Institute.
Finley and her colleagues were one of seven poster presentations. Their research project, titled “Fall prevention initiative in geriatric psychiatry”, aimed to reduce the rate of falls with injury among patients with dementia in a behavioural health unit. Within an 18-bed unit, they were able to significantly reduce falls with injury with zero incidences in the last two months of their data collection period.
Revolutionizing rehab
St. Joseph’s Health Care London is taking giant strides in the science of rehabilitation and movement, with direct benefit to patients.
St. Joseph’s is setting a long-time vision into motion.
“Five years ago, we had a vision of leveraging our long history and expertise in providing innovative rehabilitation treatments to improve the lives of people with mobility needs on a larger scale,” says Roy Butler, President and CEO of St. Joseph’s Health Care London (St. Joseph’s). “That dream has come to life.”
While experts at St. Joseph’s had the knowledge, innovative spirit and passion to achieve the vision, they needed a partner who shared the same enthusiasm.
William and Lynn Gray answered that call. With their generosity and ground-breaking investment, The Gray Centre for Mobility and Activity was created.
“Lynne and I are very pleased with the steady forward advancement of the centre’s mission since its establishment just a few short years ago,” says Bill Gray. “The innovative thinking and idea generation that seeks new solutions to the issue of mobility have really taken root. We hoped that The Gray Centre would have an impact on care ... and it has.”
“We’ve watched the development of The Gray Centre with enormous pride and are pleased to have our name associated with it, and the excellence it stands for,” adds Lynne Gray.
A unique concept
Established in 2020, The Gray Centre at St. Joseph’s Parkwood Institute is a regional hub focused on researching leading-edge treatments and interventions in mobility and activity. The centre’s unique model of linking research and care allows researchers to work side-by-side with clinicians, patients, and caregivers to uncover optimal methods for maintaining mobility throughout a person’s life.
“Scientists at The Gray Centre are leading the way in integrating technology and solutions in care to better understand how we can enhance each patient’s treatment plan to improve their functionality and ability to move,” says Butler.
Pioneering Research
More than 50 ongoing rehabilitation research projects at Parkwood Institute are exploring areas such as spinal cord and traumatic brain injury rehabilitation, pain, outcomes for amputees, virtual exercise and cognitive behavioral therapy, gait analysis as a measure of dementia progression, and stroke rehabilitation and recovery.
The Gray Centre is a catalyst and connector for these projects by investing in cutting-edge technology, providing seed grants, embedding researchers from Western University, leveraging clinical expertise, attracting world-class researchers and translating new knowledge into clinical practice by training students and clinicians, and fostering sustainable practice change.
More than $1.3 million granted through St. Joseph’s Health Care Foundation has advanced work at The Gray Centre over the past year. From researcher support to new equipment such as two transcranial magnetic stimulators, a portable handheld ultrasound and several sensored mats for gait assessment donors have stepped up to advance this work.
Leadership with Purpose
At the helm of The Gray Centre is Siobhan Schabrun, PhD, a world-renowned neuroscientist and the inaugural William and Lynne Gray Research Chair in Mobility and Activity. Thanks to a partnership with Western University’s Faculty of Health Sciences and Schulich School of Medicine & Dentistry, donor funding for the chair made through St. Joseph’s Health Care Foundation was matched, creating a $5-million endowed position.
Schabrun’s innovative research benefits people suffering from chronic pain. With a focus on non-invasive brain stimulation techniques to enhance neuroplasticity and improve mobility and activity outcomes, she and her team are, in essence, retraining the brain’s pain response. This innovative work bridges the gap between neuroscience and rehabilitation, offering new hope for individuals with musculoskeletal and neurological conditions.
Originally trained as a physiotherapist with a PhD in neuroscience from the University of Adelaide in Australia, Schabrun has attracted more than $15 million in competitive research funding and written or contributed to more than 140 scholarly publications.
FLOATing Forwards
The newest advancement is a first-in-Canada and a marvel of medical engineering that is transforming options in rehabilitation research and practice.
The Reha-Stim Medtec FLOAT system at St. Joseph’s Parkwood Institute enables patients with mobility limitations to walk, supported, without fear of falling. They "float" in a controlled environment using a combination of robotics, body-weight support and real-time feedback. The device has a harness attached to a robotic arm, which adjusts the level of support based on the patient's movements. Sensors provide continuous feedback for maximum learning and greatest benefit to physical therapists and patients alike. The FLOAT system has shown significant improvements in patients' mobility, balance and overall functional independence.
“Innovative equipment like the new FLOAT System is an example of the type of innovation that does not exist anywhere else in Canada,” says Bill Gray. “The real-life application of technologies like this are what The Gray Centre is intended to be about.”
Through the combined efforts of dedicated professionals, cutting-edge technology and philanthropist partners, St. Joseph’s Gray Centre has combined vision with passion and is transforming lives, one step at a time.
St. Joseph’s launches Health Crisis Fund to support local COVID-19 research
LONDON, ON – St. Joseph’s Health Care London and Lawson Health Research Institute have announced plans to move forward with clinical trials testing a drug that could potentially be used to prevent and treat COVID-19. St. Joseph’s Health Care Foundation will accelerate the creation of the studies by providing seed funding to get the research started through donor support. Based on the immediate need, The St. Joseph’s Health Crisis Fund has been created by St. Joseph’s Health Care Foundation to enable these and other research studies currently in development through Lawson, the research arm of St. Joseph’s.
While supporting urgent COVID-19 clinical trials will be an immediate focus, The St. Joseph’s Health Crisis Fund will also support critical patient care equipment and care and comfort items for healthcare staff and volunteers working on the frontlines of the pandemic across St. Joseph’s.
The initial clinical trials aim to study the use of hydroxychloroquine as a preventative medication and treatment for COVID-19. Led locally by Dr. Michael Silverman, Medical Director of St. Joseph’s Infectious Diseases Care Program, one trial will assess the safety and efficacy of using the drug to prevent COVID-19 in health care workers recently exposed to the virus. This trial will also assess the drug as a treatment for non-hospitalized patients with mild cases of the illness. St. Joseph’s will be one of many participating sites in the trial, which is being led by the Research Institute of the McGill University Health Centre.
“There is much debate surrounding the drug hydroxychloroquine. We do not yet know whether it’s safe or effective, and it should not be routinely recommended until we do,” says Dr. Silverman, also a Lawson Associate Scientist and city-wide Chair/Chief of Infectious Diseases. “We plan to carefully study the drug through a randomized controlled trial and assess whether it can help combat COVID-19.”
Dr. Silverman is also partnering with Dr. Michael Borrie, Geriatrician at St. Joseph’s and Lawson Scientist, on a prevention trial to test the safety and efficacy of the drug for patients and residents at Parkwood Institute who have been exposed to COVID-19. They are at a higher risk of infection, as well as serious complications and potential admission to acute care.
“Lawson researchers like Drs. Silverman and Borrie excel in rapid response research,” says Dr. David Hill, Lawson Scientific Director. “Hospital-based research is uniquely positioned to handle these types of studies, as close proximity to patients and sample collection is essential.”
St. Joseph’s Infectious Diseases Program is the only program of its kind in the region. Dr. Silverman, head of St. Joseph’s Infectious Disease program, has worked with communities in crisis in Zambia, Zimbabwe, Uganda and the rainforests of Guyana. He is working closely with other health care partners in the London and surrounding area to coordinate the region’s response to the COVID-19 pandemic.
“The Sisters of St. Joseph, who founded our organization, faced contagious diseases and other pandemics at different times in our 150+ year history,” says Michelle Campbell. “Today, it’s a different time, and a new disease. Now, more than ever, we ask our community to help us address the crisis facing us all.”
Those interested in donating to St. Joseph’s Health Crisis Fund are asked to visit St. Joseph’s Health Care Foundation’s website to learn more at sjhcfoundation.org. Donations can be made online, through direct mail submissions or by calling the Foundation directly at 519-646-6085.
-30-
Renowned for compassionate care, St. Joseph’s Health Care London is a leading academic health care centre in Canada dedicated to helping people live to their fullest by minimizing the effects of injury, disease and disability through excellence in care, teaching and research. Through partnership with Lawson Health Research Institute and our collaborative engagement with other health care and academic partners, St. Joseph’s has become an international leader in the areas of: chronic disease management; medical imaging; specialized mental health care; rehabilitation and specialized geriatrics; and surgery. St. Joseph’s operates through a wide range of hospital, clinic and long-term and community-based settings, including: St. Joseph’s Hospital; Parkwood Institute; Mount Hope Centre for Long Term Care; and the Southwest Centre for Forensic Mental Health Care. www.sjhc.london.on.ca
Lawson Health Research Institute is one of Canada’s top hospital-based research institutes, tackling the most pressing challenges in health care. As the research institute of London Health Sciences Centre and St. Joseph’s Health Care London, our innovation happens where care is delivered. Lawson research teams are at the leading-edge of science with the goal of improving health and the delivery of care for patients. Working in partnership with Western University, our researchers are encouraged to pursue their curiosity, collaborate often and share their discoveries widely. Research conducted through Lawson makes a difference in the lives of patients, families and communities around the world. To learn more, visit www.lawsonresearch.ca.
St. Joseph’s Health Care Foundation gathers, grows and grants philanthropic funds to enable St. Joseph’s Health Care London to pursue excellence in care, teaching and research. Through donor support, the foundation contributes to advances in the delivery of patient care, specialized equipment, research initiatives and capital funds at St. Joseph’s Hospital, Parkwood Hospital, Mount Hope Centre for Long Term Care, Regional Mental Health Care London and Southwest Centre for Forensic Mental Health Care and Lawson Health Research Institute. As one of the largest charitable organizations in Southwestern Ontario, St. Joseph’s Health Care Foundation is an accredited member of Imagine Canada’s Ethical Trustmark Program, which recognizes the foundation’s commitment to ethical fundraising and donor accountability. www.sjhcfoundation.org
Senior Media Relations Consultant
Communications & Public Engagement
T: 519-685-8500 ext. 73502
Celine.zadorsky@lhsc.on.ca
Student innovators showcase work at London Health Research Day 2025
The region’s largest celebration of emerging researchers’ work, London Health Research Day featured oral and poster presentations from undergraduates, grad students, postgraduates and trainees.
They shared their work with peers and globally renowned scientists in an array of specialized health and medical fields.
Their projects were as diverse as concussion treatment for children; large-language models to evaluate cancer diagnoses; brain imaging in people with dementia; and health system change to reduce surgical wait times.
Dozens of projects had Lawson Research Institute connections, included chronic pain’s impact on the brain; self-directed cognitive behavioural therapy for people recovering from stroke; and triaging care for people with shoulder injury.
Participants were also treated to a keynote address by Professor Francesca Ciccarelli, PhD, a global leader in cancer genomics who shared groundbreaking insights into the future of cancer research and precision medicine.
Her presentation was part of the Lucille and Norton Wolf Health Research Lecture Series through the generosity of the Bernard and Norton Wolf Family Foundation.
London Health Research Day is a shared project of Western’s Schulich School of Medicine & Dentistry, the Faculty of Health Sciences, Lawson Research Institute of St. Joseph's Health Care London and London Health Sciences Centre Research Institute.
All told, about 500 people took in the day’s events, including several professional- and career-development workshops.